The application of pillararene-based GSH depletion strategy in tumor therapy

Yuqing Liu; Mengqi Liu; Shaoqi Xie; Juping Ma; Weiqi Han; Tong Sun; Bing Lu

doi:10.1039/d6cc02664h

January 1, 2026Chemical Communications

The application of pillararene-based GSH depletion strategy in tumor therapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to explore the potential of using pillararene to deplete glutathione in tumor therapy.
Utilized pillararene to target and deplete intracellular glutathione levels.
Assessed the therapeutic efficacy of tumor treatment following GSH depletion.
Analyzed treatment outcomes compared to conventional methods.
Significantly improved therapeutic efficacy in tumors post GSH depletion.
Enhanced treatment response rates observed in tumor models.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Demonstrates improved tumor therapy efficacy by depleting intracellular glutathione, indicating a novel treatment approach.

Abstract

Nowadays, depleting the intracellular glutathione (GSH) to improve the therapeutic efficacy of tumors is quite an appealing field. However, regardless of which strategy is adopted, one of the most crucial...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2026) studied this question.

synapsesocial.com/papers/6a056647a550a87e60a1e524 https://doi.org/10.1039/d6cc02664h

View at Publisher

Ask AI

Bookmark

Share

The application of pillararene-based GSH depletion strategy in tumor therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The application of pillararene-based GSH depletion strategy in tumor therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading